IXICO (LON:IXI) Insider Mark Warne Acquires 50,006 Shares of Stock

IXICO plc (LON:IXI) insider Mark Warne purchased 50,006 shares of IXICO stock in a transaction on Wednesday, July 15th. The shares were acquired at an average price of GBX 8 per share, for a total transaction of £4,000.48.

IXICO Trading Down 3.0%

IXI stock opened at GBX 8 on Wednesday. The company has a market capitalization of £17.52 million, a PE ratio of -4.10, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83. IXICO plc has a one year low of GBX 6.26 and a one year high of GBX 15. The company’s 50 day moving average price is GBX 8.21 and its two-hundred day moving average price is GBX 8.71.

IXICO (LON:IXI) last announced its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The business had revenue of GBX 395 million during the quarter. As a group, analysts predict that IXICO plc will post -289.3584879 earnings per share for the current fiscal year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.